Best Financing Strategies for Oncology Practice Expansion in 2026

What is oncology practice expansion financing?

Financing for oncology practice expansion is funding used to acquire equipment, enlarge facilities, or grow services in a cancer‑care clinic.

Key financing options in 2026

1. SBA 7(a) and 504 loans

• 7(a) loan – Up to $5 million, flexible use, typical rates 5.75%–6.75% APR.
• 504 loan – Up to $5.5 million for real estate or major equipment, fixed rates around 5.25%.

According to the U.S. Small Business Administration, SBA loan approvals for health‑care businesses rose 12% in 2025, reflecting growing lender confidence in medical practice borrowers.

Source: [U.S. SBA newsroom](https://www.sba.gov/about SBA/newsroom/press-releases)

2. Equipment leasing and rent‑to‑own

Leasing is popular for high‑cost devices such as linear accelerators and PET‑CT scanners. Current market data shows the average money‑factor for radiation therapy equipment leases sits at 0.012‑0.018, equivalent to a 7%‑10% APR.

The Equipment Leasing and Finance Association (ELFA) reported that total healthcare equipment leasing volumes grew 6% in the first half of 2025, driven by demand for advanced imaging and therapy platforms.

Source: ELFA market snapshot

3. Traditional bank term loans

Region‑specific banks and credit unions still provide the lowest rates for well‑established oncology groups. A 3‑ to 7‑year term loan for a new MRI suite typically carries a 5.5%‑7.5% APR, with covenant‑free structures for practices that can demonstrate ≥$5 million in annual revenue.

4. Non‑bank specialty lenders

Fintech lenders and specialty finance firms offer faster approvals and higher loan‑to‑value (LTV) ratios (up to 85%). Rates are higher, ranging from 7% to 11% APR, but the speed‑to‑capital can be advantageous when a competitive lease‑to‑buy opportunity arises.

How to qualify for oncology clinic equipment financing 2026

1. Financial statements – Provide 2‑year audited statements; EBITDA should be ≥15% of revenue.
2. Credit profile – Maintain a personal and business FICO ≥ 680; higher scores lower rates.
3. Collateral – Equipment, real estate, or a personal guarantee is typically required.
4. Business plan – Detail projected patient volume, reimbursement mix, and ROI for the new asset.
5. SBA eligibility – Must be a for‑profit entity, meet size standards (≤$15 million in net worth), and demonstrate a sound repayment ability.

Equipment financing terms for diagnostic facilities

Financing type	Typical LTV	Term length	Fixed/Variable	Typical APR
SBA 7(a) loan	70‑80%	7‑10 years	Fixed	5.75%‑6.75%
SBA 504 loan	40% CDC‑backed, 50% private	10‑20 years	Fixed	5.25%‑5.75%
Bank term loan	60‑85%	3‑7 years	Fixed	5.5%‑7.5%
Lease (rent‑to‑own)	100% (asset)	3‑7 years	Variable (money‑factor)	7%‑10%
Fintech lender	80‑90%	2‑5 years	Fixed or variable	7%‑11%

Pros and cons of lease vs. buy for oncologists

Pros

• Leasing – Preserves cash, easier upgrades, tax‑deductible payments.
• Buying – Full ownership, Section 179 expensing, better long‑term ROI if utilization is high.

Cons

• Leasing – Higher total cost over life of asset, strict usage covenants.
• Buying – Large upfront capital, potential residual risk if technology becomes obsolete.

Common questions answered

What is the average down payment for a linear accelerator?: Most lenders require 15%‑20% of the equipment price, which translates to $300,000‑$400,000 on a $2 million device.

How long does SBA approval take for an oncology practice?: The SBA’s streamlined 7(a) process averages 21‑30 days from application to funding when documentation is complete.

Bottom line

Oncologists have multiple financing pathways—SBA loans, bank term loans, leasing, and fintech options—each with distinct cost structures and qualification criteria. Selecting the right mix depends on cash flow, credit strength, and the practice’s growth timeline.

Ready to explore rates and see if you qualify?

Disclosures

This content is for educational purposes only and is not financial advice. oncoevidence1.com may receive compensation from partner lenders, which may influence which products are featured. Rates, terms, and availability vary by lender and applicant qualifications.